Nephrogen
Biotechnology ResearchNew York, United States2-10 Employees
Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.